Lifecare Asa · OSL:LIFE
Lifecare Asa — Investor Presentation (October 2024)
20 slides from Lifecare Asa's investor presentation, October 2024
Slide 1: 2024 Q2 Report Company presentation
2024 Q2 Report 27 August 2024 Company presentation Updated October 2024
Slide 2: Disclaimer
Disclaimer The information in this presentation has been prepared by Lifecare (the “Company”). This presentation does not constitute a recommendation regarding any securities of the Company. By accepting to attend this presentation and/or receive this information, you agree to be bound by the follow
Slide 3: Company presentation
Company presentation Market & competition Lifecare’s Sencell sensor Clinical studies and progress About Lifecare 27.08.24 3
Slide 4: A Global Crisis that Remains Uncontrolled
A Global Crisis that Remains Uncontrolled Diabetes Diagnosis and Cost Global Diabetes Related Health Expenditures 783m in 2045E +27% increase Past 2 Years Source: IDF Atlas, 10th edition (2021) © LIFECARE 21.10.2024 4
Slide 5: Glucose Monitoring
Glucose Monitoring Standard treatment Blood Glucose Meter State-of-the art treatment Continuos Glucose Monitor 21.10.2024 5
Slide 6: Sensing principles – Continuous Glucose Monitoring
Sensing principles – Continuous Glucose Monitoring 1 Glucose oxidase 2 Flourescence 3 Osmotic pressure Dexcom (G6 & G7), Medtronic, Abbott Senseonics (Eversense) Lifecare (Sencell) (FreeStyle Libre 2 & 3) Longevity: 7- 14 days Longevity: 180 days Longevity: 172 days (in-vitro) Annual cost: $ 1.500 –
Slide 7: Clinical stage sensor company developing the world's smallest Continuous Glucose Monitor
Clinical stage sensor company developing the worlds smallest Continuous Glucose Monitor 21.10.2024 7
Slide 8: Sencell system
Sencell system ✓ Size of a grain of rice ✓ Injected under the skin ✓ 6 months longevity ✓ No calibration needed 21.10.2024 8
Slide 9: Clinical status
Study «LFC-SEN-001» – concluded May 2023 Clinical status presented at American Diabetes Association Scientific Sessions June 23 Purpose: Collect human proof-of-concept performance data for algorithm development during meal experiments and for further device optimization Conclusion: Subcutaneous gluc
Slide 10: Clinical accuracy – Consensus error grid
Clinical accuracy – Consensus error grid (ISO 15197: BG meters) Results in zone A and B: LFC-SEN-001: Retrospective regulatory accepted consensus error-grid analysis 21.10.2024 10
Slide 11: Documented 12 weeks longevity in live tissue
Documented 12 weeks longevity in live tissue Ongoing longevity study at in cooperation with the Veterinary institute at the Norwegian University of Life Sciences. Implant in dog has shown 12 weeks functionality with no complications during the period or after explanation. Bacteriological examination
Slide 12: One technology Two markets
One technology Two markets 21.10.2024 12
Slide 13: The potential of Lifecare in the veterinary market
The potential of Lifecare in the veterinary market USA With diabetes 85 million dogs 1 million 62 million cats 0.25 million Europe With diabetes 90 million dogs 1.1 million 120 million cats 0.5 million Number of dogs & cats that develop diabetes every year
Slide 14: Product development agreement with Sanofi
Product development agreement with Sanofi Sanofi-Avenis Group sponsor the development program for miniaturizing the Sencell Glucose sensor with funding of EUR 290.000 based on completion of defined development phases The Development Agreement is based on a robust evaluation and due diligence process
Slide 15: Progress
Progress Studies Successful in-vitro testing confirming functionality of miniaturized sensors Proof-of-concept in humans In-human study (LFC-SEN-001) confirming clinical accuracy in line with gold standard Longevity study of the Sencell sensor with operational lifetime of more than 172 days In-dogs
Slide 16: From pilot to automated production
From pilot to automated production 21.10.2024 16
Slide 17: Mainz: manufacturing facilities for volume production
Mainz: manufacturing facilities for volume production 21.10.2024 17
Slide 18: Organization
Organization Lifecare ASA Lifecare Laboratory Lifecare NanoBioSensors (Bergen, NO) (Mainz, DE) (Reutlingen, DE) Lifecare Chemistry Lifecare Veterinary RemovAid (Bristol UK) (Bergen, NO) (Lysaker, NO)
Slide 19: People
People Full-time equivalents: 33 PhD: 7 Scientifical workers: 23 PhD-students: 4 21.10.2024 19
Slide 20: © LIFECARE
© LIFECARE